What is Artivion, Inc.'s earnings per share (EPS)?

Artivion, Inc. (AORT) reported diluted earnings per share of $0.21 for fiscal year 2025. This represents a 165.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Artivion, Inc. Financials

AORT

Trailing 12 months to June 30, 2026

Revenue $471.5M +16.4% YoY

Net Income -$3.2M +82.3% YoY

EPS (Diluted) -$0.07 +83.3% YoY

Free Cash Flow -$9.2M -219.5% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Artivion, Inc. (AORT) reported $471.5M in revenue over the twelve months to Jun 30, 2026, up 16.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AORT FY2025 2026-05-08

Deleveraging and heavier reinvestment reshaped Artivion, turning accounting profit positive while leaving free cash flow nearly flat.

The earnings turn was not a gross-margin breakout: operating margin slipped to 7.7% from 10.0%, so positive net income depended more on a lighter financing burden than on cleaner core cost absorption. Cash conversion was stronger than headline profit, with operating cash flow at $39.9M but free cash flow only $839K because capex consumed most of the cash created.

Gross economics look unusually steady, which matters because it means the business is not relying on a sudden product-margin shift to explain better results. Gross margin held near 64.0% and 64.4%, so most of the volatility sits in overhead and financing costs rather than in the basic revenue-to-cost relationship.

Balance-sheet pressure eased materially as long-term debt fell to $215.1M from $314.2M, helping reduce fixed financial drag. The current ratio remains 3.5x, so even after a capex step-up the company still has meaningful short-term liquidity rather than operating hand-to-mouth.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Artivion, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Artivion, Inc. has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is down from 10.0% the prior year.

Growth

Artivion, Inc.'s revenue grew 13.6% year-over-year to $441.3M, a solid pace of expansion. This earns a growth score of 69/100.

Leverage

Artivion, Inc. has elevated debt relative to equity (D/E of 0.48), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 23/100, reflecting increased financial risk.

Liquidity

With a current ratio of 3.53, Artivion, Inc. holds $3.53 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.

Cash Flow

While Artivion, Inc. generated $39.9M in operating cash flow, capex of $39.0M consumed most of it, leaving $839K in free cash flow. This results in a low score of 33/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Artivion, Inc.'s ROE of 2.2% shows moderate profitability relative to equity, earning a score of 45/100. This is up from -4.8% the prior year.

Altman Z-Score Grey Zone

2.68

Artivion, Inc. scores 2.68, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($1.3B) relative to total liabilities ($436.6M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Artivion, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

4.08x

For every $1 of reported earnings, Artivion, Inc. generates $4.08 in operating cash flow ($39.9M OCF vs $9.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.27x

Artivion, Inc. earns $1.27 in operating income for every $1 of interest expense ($33.7M vs $26.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$441.3M

YoY+13.6%

5Y CAGR+11.8%

10Y CAGR+11.7%

Artivion, Inc. generated $441.3M in revenue in fiscal year 2025. This represents an increase of 13.6% from the prior year.

EBITDA

$56.2M

YoY-10.9%

5Y CAGR+19.4%

10Y CAGR+17.5%

Artivion, Inc.'s EBITDA was $56.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.9% from the prior year.

Net Income

$9.8M

YoY+173.1%

10Y CAGR+9.3%

Artivion, Inc. reported $9.8M in net income in fiscal year 2025. This represents an increase of 173.1% from the prior year.

EPS (Diluted)

$0.21

YoY+165.6%

10Y CAGR+4.1%

Artivion, Inc. earned $0.21 per diluted share (EPS) in fiscal year 2025. This represents an increase of 165.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$839K

YoY-92.4%

5Y CAGR-30.1%

10Y CAGR-20.1%

Artivion, Inc. generated $839K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 92.4% from the prior year.

Cash & Debt

$64.9M

YoY+21.4%

5Y CAGR+1.1%

10Y CAGR+5.6%

Artivion, Inc. held $64.9M in cash against $215.1M in long-term debt as of fiscal year 2025.

Shares Outstanding

48M

YoY+13.9%

5Y CAGR+4.2%

10Y CAGR+4.0%

Artivion, Inc. had 48M shares outstanding in fiscal year 2025. This represents an increase of 13.9% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

64.4%

YoY+0.4pp

5Y CAGR-1.9pp

10Y CAGR+2.2pp

Artivion, Inc.'s gross margin was 64.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the prior year.

Operating Margin

7.6%

YoY-2.4pp

5Y CAGR+6.7pp

10Y CAGR+4.0pp

Artivion, Inc.'s operating margin was 7.6% in fiscal year 2025, reflecting core business profitability. This is down 2.4 percentage points from the prior year.

Net Margin

2.2%

YoY+5.7pp

5Y CAGR+8.8pp

10Y CAGR-0.5pp

Artivion, Inc.'s net profit margin was 2.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.7 percentage points from the prior year.

Return on Equity

2.2%

YoY+7.0pp

5Y CAGR+7.3pp

10Y CAGR-0.4pp

Artivion, Inc.'s ROE was 2.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.0 percentage points from the prior year.

Capital Allocation

R&D Spending

$31.0M

YoY+8.9%

5Y CAGR+5.1%

10Y CAGR+11.5%

Artivion, Inc. invested $31.0M in research and development in fiscal year 2025. This represents an increase of 8.9% from the prior year.

Capital Expenditures

$39.0M

YoY+249.0%

5Y CAGR+39.7%

10Y CAGR+27.3%

Artivion, Inc. invested $39.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 249.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

AORT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AORT quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$471.5M	$441.3M+13.6%	$388.5M+9.8%	$354.0M+12.8%	$313.8M+5.0%	$298.8M+18.0%	$253.2M-8.3%	$276.2M+5.1%	$262.8M+38.6%	$189.7M+5.2%	$180.4M+23.6%	$145.9M+0.9%	$144.6M+2.8%	$140.8M+6.9%	$131.7M+10.1%	$119.6M
Cost of Revenue	$168.0M	$157.1M+12.4%	$139.8M+12.0%	$124.8M+12.2%	$111.3M+9.8%	$101.3M+18.6%	$85.4M-8.3%	$93.2M+3.7%	$89.9M+47.2%	$61.1M-0.7%	$61.5M+11.4%	$55.2M+3.4%	$53.4M+5.9%	$50.4M+7.9%	$46.7M+6.7%	$43.8M
Gross Profit	$303.5M	$284.2M+14.2%	$248.8M+8.6%	$229.2M+13.2%	$202.5M+2.5%	$197.5M+17.7%	$167.8M-8.3%	$183.0M+5.8%	$173.0M+34.5%	$128.6M+8.2%	$118.9M+31.1%	$90.7M-0.6%	$91.3M+1.0%	$90.4M+6.3%	$85.0M+12.1%	$75.8M
R&D Expenses	$35.1M	$31.0M+8.9%	$28.5M-0.9%	$28.7M-26.2%	$38.9M+9.4%	$35.5M+46.8%	$24.2M+5.4%	$23.0M-0.6%	$23.1M+18.7%	$19.5M+44.7%	$13.4M+28.8%	$10.4M+20.0%	$8.7M+2.9%	$8.5M+16.5%	$7.3M+5.2%	$6.9M
SG&A Expenses	$254.8M	$226.5M+24.8%	$181.5M-13.2%	$209.0M+32.7%	$157.4M-7.3%	$169.8M+20.3%	$141.1M-1.3%	$143.0M+1.7%	$140.6M+38.9%	$101.2M+10.6%	$91.5M+22.2%	$74.9M+1.6%	$73.8M+8.3%	$68.1M+4.5%	$65.1M+13.7%	$57.3M
Operating Income	$20.6M	$33.7M-13.2%	$38.9M+577.0%	$5.7M-7.4%	$6.2M-23.6%	$8.1M+232.5%	$2.4M-85.7%	$17.0M+83.0%	$9.3M+16.8%	$8.0M-63.5%	$21.8M+307.5%	$5.4M-39.4%	$8.8M-36.0%	$13.8M+9.6%	$12.6M+8.3%	$11.6M
Interest Expense	$24.3M	$26.6M-22.4%	$34.3M+35.5%	$25.3M+38.8%	$18.2M+7.9%	$16.9M+1.1%	$16.7M+12.1%	$14.9M-5.7%	$15.8M+222.4%	$4.9M+63.3%	$3.0M+4738.7%	$62K-64.6%	$175K+146.5%	$71K-60.3%	$179K+26.1%	$142K
Income Tax	$5.4M	$5.0M-14.3%	$5.8M-35.8%	$9.1M+116.3%	$4.2M+60014.3%	$7K+101.4%	-$492K-547.4%	-$76K+97.9%	-$3.6M-2383.2%	-$143K-101.9%	$7.6M+309.8%	$1.9M+34.9%	$1.4M-80.6%	$7.1M+73.4%	$4.1M+0.3%	$4.1M
Net Income	-$3.2M	$9.8M+173.1%	-$13.4M+56.5%	-$30.7M-59.9%	-$19.2M-29.4%	-$14.8M+11.1%	-$16.7M-1069.9%	$1.7M+160.6%	-$2.8M-176.7%	$3.7M-65.6%	$10.8M+169.1%	$4.0M-45.3%	$7.3M-54.7%	$16.2M+103.5%	$7.9M+7.8%	$7.4M
EPS (Diluted)	-$0.07	$0.21+165.6%	-$0.32+57.3%	-$0.75-56.3%	-$0.48-26.3%	-$0.38+13.6%	-$0.44-980.0%	$0.05+162.5%	-$0.08-172.7%	$0.11-65.6%	$0.32+128.6%	$0.14-44.0%	$0.25-56.1%	$0.57+103.6%	$0.28+7.7%	$0.26

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$125.8M+8.1%	$116.3M+0.3%	$116.0M+2.3%	$113.4M+0.4%	$113.0M+14.1%	$99.0M+1.7%	$97.3M+1.6%	$95.8M
Cost of Revenue	$45.2M+10.6%	$40.9M-4.6%	$42.8M+9.9%	$39.0M-2.2%	$39.9M+12.6%	$35.4M-1.1%	$35.8M+3.0%	$34.8M
Gross Profit	$80.5M+6.7%	$75.4M+3.2%	$73.1M-1.7%	$74.4M+1.8%	$73.1M+15.0%	$63.6M+3.4%	$61.5M+0.8%	$61.0M
R&D Expenses	$9.1M+2.4%	$8.8M-3.1%	$9.1M+12.9%	$8.1M+14.4%	$7.1M+5.0%	$6.7M-9.1%	$7.4M+12.1%	$6.6M
SG&A Expenses	$79.8M+31.2%	$60.8M+7.0%	$56.8M-0.8%	$57.3M-0.7%	$57.7M+5.4%	$54.7M+6.4%	$51.4M+2.8%	$50.0M
Operating Income	-$8.4M-244.5%	$5.8M-45.8%	$10.7M-14.8%	$12.5M+49.5%	$8.4M+290.9%	$2.1M-19.6%	$2.7M-39.2%	$4.4M
Interest Expense	$7.3M+35.1%	$5.4M-2.9%	$5.5M-9.6%	$6.1M-15.8%	$7.3M-5.1%	$7.7M-21.4%	$9.8M+16.1%	$8.4M
Income Tax	$1.8M+268.0%	-$1.1M-126.2%	$4.1M+642.1%	$554K-74.1%	$2.1M+219.4%	-$1.8M-1404.2%	-$119K-111.6%	$1.0M
Net Income	-$13.5M-1053.4%	$1.4M-41.6%	$2.4M-62.7%	$6.5M+383.4%	$1.3M+366.3%	-$505K+96.9%	-$16.5M-620.4%	-$2.3M
EPS (Diluted)	-$0.28-1033.3%	$0.03-40.0%	$0.05-61.5%	$0.13+333.3%	$0.03+400.0%	-$0.01+97.4%	-$0.39-680.0%	-$0.05

AORT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AORT quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$884.8M+12.1%	$789.1M-0.4%	$792.4M+3.9%	$762.8M-3.8%	$793.1M+0.5%	$789.4M+30.3%	$605.7M+6.1%	$571.1M-3.2%	$589.7M+86.5%	$316.1M+74.5%	$181.2M+2.9%	$176.2M+0.8%	$174.7M+11.2%	$157.2M+6.3%	$147.9M
Current Assets	$358.1M+23.4%	$290.1M+3.4%	$280.7M+13.5%	$247.3M-0.1%	$247.7M+5.6%	$234.6M+25.2%	$187.4M+4.6%	$179.2M-0.1%	$179.3M+21.8%	$147.2M+34.3%	$109.7M+3.4%	$106.0M-0.3%	$106.3M+37.2%	$77.5M-7.6%	$83.9M
Cash & Equivalents	$64.9M+21.4%	$53.5M-9.3%	$58.9M+49.8%	$39.4M-28.5%	$55.0M-10.4%	$61.4M+81.9%	$33.8M-18.6%	$41.5M+3.8%	$40.0M-29.4%	$56.6M+50.7%	$37.6M+12.6%	$33.4M-11.3%	$37.6M+189.4%	$13.0M-40.1%	$21.7M
Inventory	$92.4M+15.9%	$79.8M-2.7%	$82.0M+10.1%	$74.5M-3.2%	$77.0M+5.4%	$73.0M+37.6%	$53.1M+16.7%	$45.5M-2.6%	$46.7M+77.6%	$26.3M+79.6%	$14.6M+14.9%	$12.7M+30.4%	$9.8M-7.4%	$10.6M+44.2%	$7.3M
Accounts Receivable	$89.8M+13.0%	$79.5M+10.7%	$71.8M+16.1%	$61.8M+16.6%	$53.0M+15.3%	$46.0M-13.2%	$52.9M+12.4%	$47.1M-0.9%	$47.5M+71.1%	$27.8M+18.6%	$23.4M+11.2%	$21.1M+18.1%	$17.8M+11.9%	$15.9M+1.1%	$15.8M
Goodwill	$254.1M+5.5%	$241.0M-2.6%	$247.3M+1.5%	$243.6M-2.5%	$250.0M-3.9%	$260.1M+39.3%	$186.7M-1.1%	$188.8M+0.3%	$188.3M+140.5%	$78.3M+588.9%	$11.4M0.0%	$11.4M0.0%	$11.4M0.0%	$11.4M+169.3%	$4.2M
Total Liabilities	$436.6M-14.9%	$512.9M+0.4%	$510.6M+6.7%	$478.5M-2.8%	$492.3M+6.9%	$460.7M+44.0%	$320.0M+8.1%	$296.0M-5.3%	$312.6M+191.8%	$107.2M+313.3%	$25.9M-5.6%	$27.5M-8.2%	$29.9M+3.1%	$29.0M+10.3%	$26.3M
Current Liabilities	$101.6M+52.0%	$66.8M+15.5%	$57.9M+16.5%	$49.7M+10.5%	$45.0M-25.7%	$60.5M+33.8%	$45.2M+30.9%	$34.5M-19.6%	$42.9M+42.6%	$30.1M+53.5%	$19.6M-5.0%	$20.6M-0.5%	$20.7M-3.3%	$21.4M-0.1%	$21.5M
Long-Term Debt	$215.1M-31.5%	$314.2M+2.8%	$305.5M-0.3%	$306.5M-0.3%	$307.5M+5.9%	$290.5M+35.4%	$214.6M-0.5%	$215.7M-1.2%	$218.2M+225.7%	$67.0M	N/A	N/A	N/A	N/A	N/A
Total Equity	$448.2M+62.3%	$276.2M-2.0%	$281.8M-0.9%	$284.3M-5.5%	$300.7M-8.5%	$328.7M+15.1%	$285.7M+3.9%	$275.1M-0.7%	$277.1M+32.6%	$209.0M+34.6%	$155.3M+4.4%	$148.7M+2.7%	$144.7M+13.0%	$128.1M+5.4%	$121.5M
Retained Earnings	-$51.5M+15.9%	-$61.3M-27.9%	-$47.9M-178.3%	-$17.2M-971.7%	$2.0M-90.1%	$20.0M-45.5%	$36.7M+4.9%	$35.0M-7.0%	$37.6M+10.2%	$34.1M+46.1%	$23.4M+2.6%	$22.8M+21.5%	$18.7M+238.5%	$5.5M+633.8%	-$1.0M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.1B+21.4%	$883.2M-0.2%	$884.8M+3.2%	$857.7M+2.3%	$838.4M+6.0%	$791.2M+0.3%	$789.1M-1.7%	$803.1M
Current Assets	$371.4M+3.9%	$357.5M-0.2%	$358.1M+6.1%	$337.5M+5.9%	$318.8M+11.0%	$287.3M-1.0%	$290.1M+0.7%	$288.0M
Cash & Equivalents	$77.3M+38.6%	$55.8M-14.1%	$64.9M-11.6%	$73.4M+37.3%	$53.5M+41.9%	$37.7M-29.5%	$53.5M-4.8%	$56.2M
Inventory	$103.4M+5.5%	$98.0M+6.0%	$92.4M+2.1%	$90.5M+4.4%	$86.7M+5.9%	$81.9M+2.7%	$79.8M-5.2%	$84.1M
Accounts Receivable	$97.9M+6.6%	$91.9M+2.4%	$89.8M+1.9%	$88.1M-3.6%	$91.4M+4.1%	$87.8M+10.5%	$79.5M+5.0%	$75.7M
Goodwill	$349.9M+39.0%	$251.7M-1.0%	$254.1M0.0%	$254.0M+0.1%	$253.8M+3.6%	$245.1M+1.7%	$241.0M-3.1%	$248.7M
Total Liabilities	$626.3M+44.8%	$432.7M-0.9%	$436.6M+4.2%	$419.0M+0.1%	$418.5M-15.8%	$496.9M-3.1%	$512.9M+2.9%	$498.4M
Current Liabilities	$106.9M+15.4%	$92.7M-8.7%	$101.6M+18.3%	$85.8M+28.7%	$66.7M+28.4%	$51.9M-22.3%	$66.8M-56.3%	$152.8M
Long-Term Debt	$363.4M+68.8%	$215.4M+0.1%	$215.1M+0.1%	$214.9M-0.3%	$215.5M-31.5%	$314.6M+0.1%	$314.2M+46.6%	$214.3M
Total Equity	$445.6M-1.1%	$450.5M+0.5%	$448.2M+2.2%	$438.7M+4.5%	$419.9M+42.7%	$294.3M+6.5%	$276.2M-9.4%	$304.7M
Retained Earnings	-$63.6M-27.0%	-$50.1M+2.8%	-$51.5M+4.5%	-$53.9M+10.8%	-$60.4M+2.2%	-$61.8M-0.8%	-$61.3M-36.8%	-$44.8M

AORT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AORT quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$41.7M	$39.9M+79.3%	$22.2M+18.1%	$18.8M+465.3%	-$5.2M-99.3%	-$2.6M-120.9%	$12.4M-21.8%	$15.8M+60.2%	$9.9M-8.5%	$10.8M-45.2%	$19.7M+72.3%	$11.4M+40.9%	$8.1M-51.6%	$16.8M-11.7%	$19.0M+13.4%	$16.8M
Capital Expenditures	$50.9M	$39.0M+249.0%	$11.2M+14.7%	$9.8M-9.0%	$10.7M-18.1%	$13.1M+78.6%	$7.3M-9.2%	$8.1M+39.5%	$5.8M-12.8%	$6.6M+7.0%	$6.2M+77.6%	$3.5M-19.0%	$4.3M-0.6%	$4.3M+41.3%	$3.1M+21.0%	$2.5M
Free Cash Flow	-$9.2M	$839K-92.4%	$11.0M+21.8%	$9.1M+157.2%	-$15.9M-1.2%	-$15.7M-411.0%	$5.0M-35.0%	$7.8M+89.4%	$4.1M-1.8%	$4.2M-69.2%	$13.5M+70.0%	$8.0M+108.8%	$3.8M-69.4%	$12.4M-21.9%	$15.9M+12.0%	$14.2M
Investing Cash Flow	-$175.0M	-$42.0M-49.1%	-$28.2M-5515.1%	-$502K+95.3%	-$10.7M-289.3%	$5.7M+107.7%	-$73.1M-205.4%	-$23.9M-256.6%	-$6.7M+96.1%	-$171.0M-116.8%	-$78.9M-1659.0%	-$4.5M	N/A	N/A	-$22.9M+17.3%	-$27.7M
Financing Cash Flow	$157.6M	$11.3M+412.1%	$2.2M+154.7%	$865K+152.8%	-$1.6M+86.6%	-$12.2M-113.1%	$93.6M+6369.8%	-$1.5M+41.7%	-$2.6M-101.8%	$143.2M+95.1%	$73.4M+2713.1%	-$2.8M	N/A	N/A	-$4.7M-65.7%	-$2.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.4M+3.4%	$3.3M+11.1%	$3.0M+116.1%	$1.4M	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5.6M+266.9%	$1.5M-54.0%	$3.3M+8.0%	$3.1M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$1.3M-209.7%	$1.2M-94.1%	$19.6M-12.1%	$22.3M+48.3%	$15.0M+188.5%	-$17.0M-267.2%	$10.1M-11.5%	$11.5M
Capital Expenditures	$10.7M+34.3%	$8.0M-70.9%	$27.5M+496.8%	$4.6M+40.2%	$3.3M-9.6%	$3.6M+155.3%	$1.4M-60.8%	$3.6M
Free Cash Flow	-$12.0M-75.4%	-$6.8M+13.8%	-$7.9M-145.0%	$17.7M+50.6%	$11.7M+156.9%	-$20.6M-336.3%	$8.7M+11.5%	$7.8M
Investing Cash Flow	-$129.4M-1132.1%	-$10.5M+65.6%	-$30.5M-561.9%	-$4.6M-40.2%	-$3.3M+9.6%	-$3.6M+68.2%	-$11.4M-7.4%	-$10.6M
Financing Cash Flow	$152.4M+32813.2%	$463K-80.9%	$2.4M+4.9%	$2.3M-10.8%	$2.6M-34.0%	$3.9M+2162.6%	$174K-88.2%	$1.5M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AORT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AORT quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	64.4%+0.4pp	64.0%-0.7pp	64.7%+0.2pp	64.5%-1.6pp	66.1%-0.2pp	66.3%0.0pp	66.3%+0.4pp	65.8%-2.0pp	67.8%+1.9pp	65.9%+3.7pp	62.2%-0.9pp	63.1%-1.1pp	64.2%-0.3pp	64.5%+1.1pp	63.4%
Operating Margin	7.6%-2.4pp	10.0%+8.4pp	1.6%-0.4pp	2.0%-0.7pp	2.7%+1.8pp	1.0%-5.2pp	6.2%+2.6pp	3.5%-0.7pp	4.2%-7.9pp	12.1%+8.4pp	3.7%-2.4pp	6.1%-3.7pp	9.8%+0.2pp	9.6%-0.2pp	9.7%
Net Margin	2.2%+5.7pp	-3.4%+5.2pp	-8.7%-2.6pp	-6.1%-1.2pp	-5.0%+1.6pp	-6.6%-7.2pp	0.6%+1.7pp	-1.1%-3.0pp	1.9%-4.0pp	6.0%+3.2pp	2.8%-2.3pp	5.1%-6.4pp	11.5%+5.5pp	6.0%-0.1pp	6.2%
Return on Equity	2.2%+7.0pp	-4.8%+6.0pp	-10.9%-4.1pp	-6.8%-1.8pp	-4.9%+0.1pp	-5.1%-5.7pp	0.6%+1.6pp	-1.0%-2.4pp	1.3%-3.8pp	5.2%+2.6pp	2.6%-2.3pp	4.9%-6.2pp	11.2%+5.0pp	6.2%+0.1pp	6.1%
Return on Assets	1.1%+2.8pp	-1.7%+2.2pp	-3.9%-1.3pp	-2.5%-0.6pp	-1.9%+0.2pp	-2.1%-2.4pp	0.3%+0.8pp	-0.5%-1.1pp	0.6%-2.8pp	3.4%+1.2pp	2.2%-1.9pp	4.2%-5.1pp	9.3%+4.2pp	5.1%+0.1pp	5.0%
Current Ratio	3.53-0.8x	4.34-0.5x	4.85-0.1x	4.98-0.5x	5.51+1.6x	3.88-0.3x	4.15-1.0x	5.19+1.0x	4.18-0.7x	4.89-0.7x	5.59+0.5x	5.140.0x	5.13+1.5x	3.62-0.3x	3.91
Debt-to-Equity	0.48-0.7x	1.14+0.1x	1.080.0x	1.08+0.1x	1.02+0.1x	0.88+0.1x	0.750.0x	0.780.0x	0.79+0.5x	0.32+0.2x	0.170.0x	0.180.0x	0.210.0x	0.230.0x	0.22
FCF Margin	0.2%-2.7pp	2.8%+0.3pp	2.6%+7.6pp	-5.1%+0.2pp	-5.3%-7.2pp	2.0%-0.8pp	2.8%+1.3pp	1.6%-0.6pp	2.2%-5.3pp	7.5%+2.0pp	5.5%+2.8pp	2.6%-6.2pp	8.8%-3.3pp	12.1%+0.2pp	11.9%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	64.0%-0.8pp	64.8%+1.8pp	63.1%-2.5pp	65.6%+0.9pp	64.7%+0.5pp	64.2%+1.0pp	63.2%-0.5pp	63.7%
Operating Margin	-6.7%-11.6pp	5.0%-4.2pp	9.2%-1.9pp	11.1%+3.6pp	7.4%+5.3pp	2.2%-0.6pp	2.7%-1.8pp	4.6%
Net Margin	-10.7%-12.0pp	1.2%-0.9pp	2.1%-3.6pp	5.7%+4.5pp	1.2%+1.7pp	-0.5%+16.4pp	-16.9%-14.5pp	-2.4%
Return on Equity	-3.0%-3.3pp	0.3%-0.2pp	0.5%-0.9pp	1.5%+1.2pp	0.3%+0.5pp	-0.2%+5.8pp	-6.0%-5.2pp	-0.8%
Return on Assets	-1.3%-1.4pp	0.2%-0.1pp	0.3%-0.5pp	0.8%+0.6pp	0.2%+0.2pp	-0.1%+2.0pp	-2.1%-1.8pp	-0.3%
Current Ratio	3.47-0.4x	3.86+0.3x	3.53-0.4x	3.93-0.9x	4.78-0.7x	5.53+1.2x	4.34+2.5x	1.88
Debt-to-Equity	0.82+0.3x	0.480.0x	0.480.0x	0.490.0x	0.51-0.6x	1.07-0.1x	1.14+0.4x	0.70
FCF Margin	-9.6%-3.7pp	-5.9%+1.0pp	-6.9%-22.4pp	15.6%+5.2pp	10.4%+31.2pp	-20.8%-29.8pp	9.0%+0.8pp	8.2%

Similar Companies

Enovis Corp ENOV

$1.5B

Conmed Corp CNMD

$1.5B

Ufp Technologies UFPT

$2.4B

Novocure NVCR

$2.1B

Integra Lifesciences Hldgs Cp IART

$1.3B

Where Artivion, Inc. Ranks

Frequently Asked Questions

What is Artivion, Inc.'s annual revenue?

Artivion, Inc. (AORT) reported $441.3M in total revenue for fiscal year 2025. This represents a 13.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Artivion, Inc.'s revenue growing?

Artivion, Inc. (AORT) revenue grew by 13.6% year-over-year, from $388.5M to $441.3M in fiscal year 2025.

Is Artivion, Inc. profitable?

Yes, Artivion, Inc. (AORT) reported a net income of $9.8M in fiscal year 2025, with a net profit margin of 2.2%.

What is Artivion, Inc.'s EBITDA?

Artivion, Inc. (AORT) had EBITDA of $56.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Artivion, Inc. have?

As of fiscal year 2025, Artivion, Inc. (AORT) had $64.9M in cash and equivalents against $215.1M in long-term debt.

What is Artivion, Inc.'s gross margin?

Artivion, Inc. (AORT) had a gross margin of 64.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Artivion, Inc.'s operating margin?

Artivion, Inc. (AORT) had an operating margin of 7.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Artivion, Inc.'s net profit margin?

Artivion, Inc. (AORT) had a net profit margin of 2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Artivion, Inc.'s return on equity (ROE)?

Artivion, Inc. (AORT) has a return on equity of 2.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Artivion, Inc.'s free cash flow?

Artivion, Inc. (AORT) generated $839K in free cash flow during fiscal year 2025. This represents a -92.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Artivion, Inc.'s operating cash flow?

Artivion, Inc. (AORT) generated $39.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Artivion, Inc.'s total assets?

Artivion, Inc. (AORT) had $884.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Artivion, Inc.'s capital expenditures?

Artivion, Inc. (AORT) invested $39.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Artivion, Inc. spend on research and development?

Artivion, Inc. (AORT) invested $31.0M in research and development during fiscal year 2025.

How many shares does Artivion, Inc. have outstanding?

Artivion, Inc. (AORT) had 48M shares outstanding as of fiscal year 2025.

What is Artivion, Inc.'s current ratio?

Artivion, Inc. (AORT) had a current ratio of 3.53 as of fiscal year 2025, which is generally considered healthy.

What is Artivion, Inc.'s debt-to-equity ratio?

Artivion, Inc. (AORT) had a debt-to-equity ratio of 0.48 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Artivion, Inc.'s return on assets (ROA)?

Artivion, Inc. (AORT) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Artivion, Inc.'s Altman Z-Score?

Artivion, Inc. (AORT) has an Altman Z-Score of 2.68, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Artivion, Inc.'s Piotroski F-Score?

Artivion, Inc. (AORT) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Artivion, Inc.'s earnings high quality?

Artivion, Inc. (AORT) has an earnings quality ratio of 4.08x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Artivion, Inc. cover its interest payments?

Artivion, Inc. (AORT) has an interest coverage ratio of 1.27x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Artivion, Inc.?

Artivion, Inc. (AORT) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.